225 related articles for article (PubMed ID: 32276897)
1. Effect of processing methods on xylitol-starch base co-processed adjuvant for orally disintegrating tablet application.
Bin LK; Helaluddin ABM; Islam Sarker MZ; Mandal UK; Gaurav A
Pak J Pharm Sci; 2020 Mar; 33(2):551-559. PubMed ID: 32276897
[TBL] [Abstract][Full Text] [Related]
2. Development of a Novel Co-processed Excipitient Comprising of Xylitol, Mannitol, Microcrystalline Cellulose, and Crospovidone for the Compounding of Memantine Hydrochloride Orally Disintegrating Tablet.
Hazdi SN; Phang HC; Ng ZQ; Chew YL; Uddin AH; Sarker ZI; Lee SK; Liew KB
Int J Pharm Compd; 2023; 27(6):522-527. PubMed ID: 38100670
[TBL] [Abstract][Full Text] [Related]
3. Investigation on the effect of polymer and starch on the tablet properties of lyophilized orally disintegrating tablet.
Liew KB; Peh KK
Arch Pharm Res; 2021 Aug; 44(8):1-10. PubMed ID: 25579848
[TBL] [Abstract][Full Text] [Related]
4. Application of Co-processed Excipient as a Novel Method to Compound Orally Disintegrating Tablets.
Liew KB; Hii SH; Chew YL; Ming LC; Uddin AH; Sarker ZI
Int J Pharm Compd; 2022; 26(3):255-263. PubMed ID: 35657749
[TBL] [Abstract][Full Text] [Related]
5. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C
Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963
[TBL] [Abstract][Full Text] [Related]
6. Development of a novel direct compressible co-processed excipient and its application for formulation of Mirtazapine orally disintegrating tablets.
Loke YH; Chew YL; Janakiraman AK; Lee SK; Uddin ABMH; Goh CF; Kee PE; Ng HS; Ming LC; Liew KB
Drug Dev Ind Pharm; 2024 Jan; 50(1):36-44. PubMed ID: 38149637
[TBL] [Abstract][Full Text] [Related]
7. Taste-masked and affordable donepezil hydrochloride orally disintegrating tablet as promising solution for non-compliance in Alzheimer's disease patients.
Liew KB; Tan YT; Peh KK
Drug Dev Ind Pharm; 2015 Apr; 41(4):583-93. PubMed ID: 24495273
[TBL] [Abstract][Full Text] [Related]
8. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
Int J Pharm; 2009 Dec; 382(1-2):80-7. PubMed ID: 19686825
[TBL] [Abstract][Full Text] [Related]
9. Orally disintegrating tablet of novel salt of antiepileptic drug: formulation strategy and evaluation.
Rahman Z; Siddiqui A; Khan MA
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1300-9. PubMed ID: 23800704
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo correlation of disintegration and bitter taste masking using orally disintegrating tablet containing ion exchange resin-drug complex.
Kim JI; Cho SM; Cui JH; Cao QR; Oh E; Lee BJ
Int J Pharm; 2013 Oct; 455(1-2):31-9. PubMed ID: 23933050
[TBL] [Abstract][Full Text] [Related]
11. Formulation and Evaluation of Baclofen-Meloxicam Orally Disintegrating Tablets (ODTs) Using Co-Processed Excipients and Improvement of ODTs Performance Using Six Sigma Method.
Abdelmonem R; Abdellatif MM; Al-Samadi IEI; El-Nabarawi MA
Drug Des Devel Ther; 2021; 15():4383-4402. PubMed ID: 34690500
[TBL] [Abstract][Full Text] [Related]
12. An in vitro analysis of disintegration times of different formulations of olanzapine orodispersible tablet: a preliminary report.
Hobbs D; Karagianis J; Treuer T; Raskin J
Drugs R D; 2013 Dec; 13(4):281-8. PubMed ID: 24170256
[TBL] [Abstract][Full Text] [Related]
13. Stability and repeatability of a continuous twin screw granulation and drying system.
Vercruysse J; Delaet U; Van Assche I; Cappuyns P; Arata F; Caporicci G; De Beer T; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1031-8. PubMed ID: 23702273
[TBL] [Abstract][Full Text] [Related]
14. [Application of β-cyclodextrin in the formulation of ODT tablets containing ibuprofen].
Zimmer Ł; Kasperek R; Poleszak E
Polim Med; 2014; 44(4):231-5. PubMed ID: 25932904
[TBL] [Abstract][Full Text] [Related]
15. Influence of sodium starch glycolate, croscarmellose sodium and crospovidone on disintegration and dissolution of stevia-loaded tablets.
Yousaf AM; Naheed F; Shahzad Y; Hussain T; Mahmood T
Polim Med; 2019; 49(1):19-26. PubMed ID: 31756060
[TBL] [Abstract][Full Text] [Related]
16. A Promising Single Oral Disintegrating Tablet for Co-Delivery of Pitavastatin Calcium and Lornoxicam Using Co-Processed Excipients: Formulation, Characterization and Pharmacokinetic Study.
Teaima MH; Abdel-Haleem KM; Osama R; El-Nabarawi MA; Elnahas OS
Drug Des Devel Ther; 2021; 15():4229-4242. PubMed ID: 34675486
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Disintegrant-addition Methods on the Compounding of Orodispersible Tablets.
Mahesparan VA; Bin Abd Razak FS; Ming LC; Uddin AH; Sarker MZI; Bin LK
Int J Pharm Compd; 2020; 24(2):148-155. PubMed ID: 32196477
[TBL] [Abstract][Full Text] [Related]
18. Formulation and Taste Masking of Ranitidine Orally Disintegrating Tablet.
Hesari Z; Shafiee A; Hooshfar S; Mobarra N; Mortazavi SA
Iran J Pharm Res; 2016; 15(4):677-686. PubMed ID: 28243264
[TBL] [Abstract][Full Text] [Related]
19. Use of a continuous twin screw granulation and drying system during formulation development and process optimization.
Vercruysse J; Peeters E; Fonteyne M; Cappuyns P; Delaet U; Van Assche I; De Beer T; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2015 Jan; 89():239-47. PubMed ID: 25528462
[TBL] [Abstract][Full Text] [Related]
20. Maltodextrin: a novel excipient used in sugar-based orally disintegrating tablets and phase transition process.
Elnaggar YS; El-Massik MA; Abdallah OY; Ebian AE
AAPS PharmSciTech; 2010 Jun; 11(2):645-51. PubMed ID: 20405257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
